TIMP2, TIMP metallopeptidase inhibitor 2, 7077

N. diseases: 404; N. variants: 20
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.050 Biomarker disease BEFREE Increased pre-ablation level of ANP, BNP, NT-pro-BNP, IL-6, C-reactive protein, LDL, and TIMP-2 was associated with greater risk of AF recurrence after RFCA. 27386883 2017
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.050 Biomarker disease BEFREE These results demonstrate that MMP‑7 and BAX were highly expressed, while TIMP‑2 and BCL‑2 were downregulated in a Beagle dog model of AF, indicating that MMP‑7 and apoptosis‑associated genes (TIMP‑2, BAX and BCL‑2) may be associated with the pathogenesis of AF. 28901395 2017
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.050 Biomarker disease BEFREE This upregulated expression and activity were positively correlated with higher regulatory indicators of atrial structural remodeling as reflected by higher transcripts of tumor necrosis factor (TNF)-related apoptosis-inducing ligand, matrix metalloproteinase (MMP)-2 and MMP-9, pro-inflammatory factors TNF-α and interleukin-6, and higher ratios of MMP-9/tissue inhibitor of metalloproteinase (TIMP)-1 and MMP-2/TIMP-2 in AF. 22001292 2011
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.050 GeneticVariation disease BEFREE Both genotype distribution and allele frequency of the TIMP-2 -418G>C polymorphism were significantly different between the AF and control group (P=0.005 and P=0.001, respectively). 20138860 2010
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.050 Biomarker disease BEFREE Tissue inhibitors of metalloproteinases (TIMP2) was significantly enhanced only in RAA-AF. 18194448 2008